AL淀粉样变性肾移植的长期结局
该研究回顾性分析了1987至2017年间49例在波士顿大学淀粉样变性中心随访并接受肾移植的AL淀粉样变性患者的临床与实验室数据。中位随访7.2年,患者从诊断起中位生存15.4年,从肾移植起中位生存10.5年,1年、3年、5年移植物存活率分别为94%、89%、81%。移植前达血液学完全缓解或非常好的部分缓解者,患者生存及移植物存活均显著优于部分缓解或无缓解者。
要点
- AL淀粉样变性患者肾移植后中位患者生存10.5年,5年移植物存活率81%。
- 移植前达血液学完全缓解或非常好的部分缓解者预后显著更优。
- 肾移植在经严格筛选的AL淀粉样变性患者中可获得良好结局。
核心结论
- 肾移植在经严格筛选的AL淀粉样变性患者中可获得良好结局,尤其移植时已达完全缓解或非常好的部分缓解者。
研究设计与样本
- 回顾性研究,纳入1987-2017年间在波士顿大学淀粉样变性中心随访并在美国某中心接受肾移植的49例AL淀粉样变性患者。
主要发现
- 中位随访7.2年(范围0-19),从诊断起中位患者生存15.4年,从肾移植起中位患者生存10.5年。
- 1年、3年、5年移植物存活率分别为94%、89%、81%。
- 移植前达血液学完全缓解或非常好的部分缓解者,患者生存显著优于部分缓解或无缓解者。
- 移植前达完全缓解或非常好的部分缓解者中位移植物丢失时间为10.4年,部分缓解或无缓解者为5.5年。
临床怎么用
- 对经严格筛选、尤其移植时已达血液学完全缓解或非常好的部分缓解的AL淀粉样变性患者,可考虑肾移植。
局限性
- 为回顾性单中心队列研究,样本量49例,数据来自特定中心,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Therapies for AL amyloidosis have dramatically improved, leading to longer patient survival; however, more AL amyloidosis patients are reaching end-stage renal disease (ESRD). There are no clear guidelines regarding eligibility for kidney transplantation in patients with AL amyloidosis, and data on outcomes are limited. We evaluated the clinical and laboratory data of 49 patients who were followed in the Amyloidosis Center at Boston University and underwent kidney transplantation at a center in the United States between 1987-2017. During a median follow-up of 7.2 years (range 0-19), the median patient survival from diagnosis was 15.4 years, and from kidney transplantation was 10.5 years. One, three, and five-year graft survival were 94%, 89%, and 81%, respectively. Patients with hematologic complete response or very good partial response prior to kidney transplantation had significantly better patient survival than patients with partial response or no response, and the median time to graft loss was 10.4 years versus 5.5 years, respectively. This is the largest published series of kidney transplantation in patients with AL amyloidosis, suggesting that kidney transplantation can have a good outcome in carefully selected patients, particularly in those who have achieved a complete response or very good partial response at the time of kidney transplantation.
引用
- Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2018. PMID: 30580886. doi:10.1016/j.kint.2018.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。